| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced molecular imaging for the characterisation of complex medicines
|
Yilmaz, Duygu
|
|
|
27 |
6 |
p. 1716-1723
|
article
|
| 2 |
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin
|
Rossi Sebastiano, Matteo
|
|
|
27 |
6 |
p. 1652-1660
|
article
|
| 3 |
Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit
|
Chen, Wenteng
|
|
|
27 |
6 |
p. 1545-1553
|
article
|
| 4 |
Contents page
|
|
|
|
27 |
6 |
p. i-ii
|
article
|
| 5 |
Defining clinical outcome pathways
|
Korn, Daniel
|
|
|
27 |
6 |
p. 1671-1678
|
article
|
| 6 |
Democratizing data at Novartis through clinical trial data access
|
Eichler, Gabriel S.
|
|
|
27 |
6 |
p. 1533-1537
|
article
|
| 7 |
Effects on bone regeneration of single-dose treatment with osteogenic small molecules
|
Lo, Kevin W.-H.
|
|
|
27 |
6 |
p. 1538-1544
|
article
|
| 8 |
Engineering nanobodies for next-generation molecular imaging
|
Yang, Erpeng
|
|
|
27 |
6 |
p. 1622-1638
|
article
|
| 9 |
Exploiting protease activation for therapy
|
Bleuez, Chloe
|
|
|
27 |
6 |
p. 1743-1754
|
article
|
| 10 |
Histone deacetylase inhibitor-based oncolytic virotherapy: A promising strategy for cancer treatment
|
Shirbhate, Ekta
|
|
|
27 |
6 |
p. 1689-1697
|
article
|
| 11 |
How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment?
|
Séguy, Line
|
|
|
27 |
6 |
p. 1575-1589
|
article
|
| 12 |
Machine learning to design antimicrobial combination therapies: Promises and pitfalls
|
Cantrell, Jennifer M.
|
|
|
27 |
6 |
p. 1639-1651
|
article
|
| 13 |
Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective
|
Ahmadi, Ali
|
|
|
27 |
6 |
p. 1679-1688
|
article
|
| 14 |
Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancer
|
Iyengar, Disha
|
|
|
27 |
6 |
p. 1554-1559
|
article
|
| 15 |
New therapy strategies in the management of breast cancer
|
Yardim-Akaydin, Sevgi
|
|
|
27 |
6 |
p. 1755-1762
|
article
|
| 16 |
Oncological drug discovery: AI meets structure-based computational research
|
Gorostiola González, Marina
|
|
|
27 |
6 |
p. 1661-1670
|
article
|
| 17 |
Orphan drug development: The impact of regulatory and reimbursement frameworks
|
Huang, Yu-Jun
|
|
|
27 |
6 |
p. 1724-1732
|
article
|
| 18 |
Patents, trade secrets and pricing
|
Kinch, Michael S.
|
|
|
27 |
6 |
p. 1531-1532
|
article
|
| 19 |
Real-world data in drug development strategies for orphan drugs: Tafasitamab in B-cell lymphoma, a case study for an approval based on a single-arm combination trial
|
Serrano, Philippe
|
|
|
27 |
6 |
p. 1706-1715
|
article
|
| 20 |
Recent advances in metabolomics analysis for early drug development
|
Alarcon-Barrera, Juan Carlos
|
|
|
27 |
6 |
p. 1763-1773
|
article
|
| 21 |
Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds
|
Proj, Matic
|
|
|
27 |
6 |
p. 1733-1742
|
article
|
| 22 |
Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory
|
Beck, Hartmut
|
|
|
27 |
6 |
p. 1560-1574
|
article
|
| 23 |
Stimuli-sensitive drug delivery systems for site-specific antibiotic release
|
Nazir, Faiqa
|
|
|
27 |
6 |
p. 1698-1705
|
article
|
| 24 |
Translating pharmacology models effectively to predict therapeutic benefit
|
Dudal, Sherri
|
|
|
27 |
6 |
p. 1604-1621
|
article
|
| 25 |
Ultrasound-activated nanomaterials for sonodynamic cancer theranostics
|
Wu, Nan
|
|
|
27 |
6 |
p. 1590-1603
|
article
|
| 26 |
Unraveling antimicrobial resistance using metabolomics
|
Kok, Maik
|
|
|
27 |
6 |
p. 1774-1783
|
article
|
Journal description